Cookie consent

This website uses cookies to collect information about how you use this website. Atkin Chambers uses this information to make the website work as well as possible and improve the services provided by members and staff. You may choose to accept all cookies or chose to manage your cookie settings here:

Cookies on atkinchambers.com

Cookies are files saved on your phone, tablet or computer when you visit a website.

Atkin Chambers uses this information to make the website work as well as possible and improve the services provided by members and staff. You may choose to accept all cookies or chose to manage your cookie settings here:

Cookie settings

Atkin Chambers Limited use two types of cookie files, analytical cookies and necessary cookies. You can choose which cookies you are happy for us to use.

Analytical cookies that measure website use

Atkin Chambers Limited use Google Analytics to measure how you use the website so it can be improved based on user needs. Atkin Chambers do not allow Google to use or share the data about how you use this site.

Google Analytics sets cookies that store anonymised information about:

  • how you got to the site
  • the pages you visit on atkinchambers.com, and how long you spend on each page
  • what you click on while you’re visiting the site

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (for example if you register for updates). They always need to be on.

Save changes

Julie Demeritt

Julie Demeritt


Chief Operating Officer

Julie Demeritt is the chief operating officer at Atkin Chambers and is responsible for the daily operation of Chambers.

Julie is a qualified barrister having been called to the Bar in November 2014.

Prior to joining Chambers in 2016, Julie spent the previous two years at the General Council of the Bar, first as policy analyst for remuneration and the employed Bar, and then as policy manager for professional standards at the Bar Standards Board.

For over 10 years, before qualifying as a barrister, Julie was a senior research scientist for AstraZeneca pharmaceuticals, researching and synthesising ground-breaking drugs for biological evaluation to cure cancer.

Julie is a member of the Legal Practice Managers’ Association, the Institute of Barristers’ Clerks and the Society of Construction Law.